我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

In Silico Target Discovery Harnessing Data and Technology for Drug Development

Ujjal Simmen

In the rapidly evolving landscape of drug development, in silico target discovery has emerged as a transformative strategy that harnesses the power of data and technology to identify potential drug targets. This computational approach involves the analysis of diverse biological datasets, molecular interactions, and intricate networks to pinpoint key proteins or genes associated with disease pathways. Through the integration of high-throughput technologies, bioinformatics tools, and virtual screening methods, in silico target discovery offers a more efficient and targeted approach to identifying therapeutic targets. This article explores the principles and applications of in silico target discovery, highlighting its potential to revolutionize drug development by expediting target identification, enhancing precision, and paving the way for personalized medicine.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。